RespireRx Pharmaceuticals Inc.
RSPI · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $1 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $3 | $2 | $2 | $2 |
| Enterprise Value | $3 | $3 | $2 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2 | $0 | -$4 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$2 | -$4 | -$5 | -$3 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.036 | -0.04 | -0.22 | -6.45 |
| % Growth | 10.5% | 81.9% | 96.6% | – |
| Operating Cash Flow | -$0 | -$1 | -$1 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$1 | -$1 | -$0 |